Citation:
张俊, 李印, 于永魁, 朱军伟, 李浩淼, 华胸怀, 孟凡宇. 吉非替尼治疗后行手术切除肺粘液表皮样癌一例. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2014, 21(3): 379-379. doi: 10.7507/1007-4848.20140104
Copy
Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved
1. |
Collby T, Koss M, Travis W. Chief editor. Tumors of salivary gland type.In Tumors of the lower respiratory tract. Washington DC:Armed Forces Institute of Pathology, 1995. 65-89.
|
2. |
Han SW, Kim AP, Jeon YK, et al. Mucoepidermoid carcinoma of lung:potential target of EGFR-directed treatment. Lung Cancer, 2008, 61 (1):30-34.
|
3. |
O'Neill ID. translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma. Oral Oncol, 2009, 45 (1):2-9.
|
4. |
Chen Z, Chen J, Gu Y, et al. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene, 2013 Aug 26. doi:10.1038/onc.2013.348.[Epub ahead of print].
|
- 1. Collby T, Koss M, Travis W. Chief editor. Tumors of salivary gland type.In Tumors of the lower respiratory tract. Washington DC:Armed Forces Institute of Pathology, 1995. 65-89.
- 2. Han SW, Kim AP, Jeon YK, et al. Mucoepidermoid carcinoma of lung:potential target of EGFR-directed treatment. Lung Cancer, 2008, 61 (1):30-34.
- 3. O'Neill ID. translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma. Oral Oncol, 2009, 45 (1):2-9.
- 4. Chen Z, Chen J, Gu Y, et al. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene, 2013 Aug 26. doi:10.1038/onc.2013.348.[Epub ahead of print].